Dr Orianne WAGNER-BALLON

Results: 13

1.
Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?
Redjoul R, Toma A, Hicheri Y, El Maaroufi H, Maertens J, Vigouroux S, Lioure B, Machaczka M, Pautas C, Bories D, Wagner-Ballon O, Gaulard P, Martin-Garcia N, Maury S, Cordonnier C.
Eur J Haematol
. 2012 May;88(5):458-60. doi: 10.1111/j.1600-0609.2012.01757.x. Epub 2012 Feb 14. No abstract available.
PMID: 22268532
[PubMed - indexed for MEDLINE]
Related citations
2.
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
Bluteau D, Gilles L, Hilpert M, Antony-Debré I, James C, Debili N, Camara-Clayette V, Wagner-Ballon O, Cordette-Lagarde V, Robert T, Ripoche H, Gonin P, Swierczek S, Prchal J, Vainchenker W, Favier R, Raslova H.
Blood
. 2011 Dec 8;118(24):6310-20. Epub 2011 Jul 1.
PMID: 21725049
[PubMed - indexed for MEDLINE]
Related citations
3.
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
Quivoron C, Couronné L, Della Valle V, Lopez CK, Plo I, Wagner-Ballon O, Do Cruzeiro M, Delhommeau F, Arnulf B, Stern MH, Godley L, Opolon P, Tilly H, Solary E, Duffourd Y, Dessen P, Merle-Beral H, Nguyen-Khac F, Fontenay M, Vainchenker W, Bastard C, Mercher T, Bernard OA.
Cancer Cell
. 2011 Jul 12;20(1):25-38. Epub 2011 Jun 30.
PMID: 21723201
[PubMed - indexed for MEDLINE]
Related citations
4.
LYL-1 deficiency induces a stress erythropoiesis.
Capron C, Lacout C, Lécluse Y, Wagner-Ballon O, Kaushik AL, Cramer-Bordé E, Sablitzky F, Duménil D, Vainchenker W.
Exp Hematol. 2011 Jun;39(6):629-42. Epub 2011 Mar 21.
PMID: 21420467
[PubMed - indexed for MEDLINE]
Related citations
5.
Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.
Smadja DM, d'Audigier C, Bièche I, Evrard S, Mauge L, Dias JV, Labreuche J, Laurendeau I, Marsac B, Dizier B, Wagner-Ballon O, Boisson-Vidal C, Morandi V, Duong-Van-Huyen JP, Bruneval P, Dignat-George F, Emmerich J, Gaussem P.
Arterioscler Thromb Vasc Biol
. 2011 Mar;31(3):551-9. Epub 2010 Dec 9.
PMID: 21148423
[PubMed - indexed for MEDLINE]
Free Article
Related citations
6.
Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis.
Evrard S, Bluteau O, Tulliez M, Rameau P, Gonin P, Zetterberg E, Palmblad J, Bonnefoy A, Villeval JL, Vainchenker W, Giraudier S, Wagner-Ballon O.
Blood
. 2011 Jan 6;117(1):246-9. Epub 2010 Oct 13.
PMID: 20944070
[PubMed - indexed for MEDLINE]
Free Article
Related citations
7.
The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development.
Ragu C, Boukour S, Elain G, Wagner-Ballon O, Raslova H, Debili N, Olson EN, Daegelen D, Vainchenker W, Bernard OA, Penard-Lacronique V.
Leukemia
. 2010 Jun;24(6):1227-30. Epub 2010 Apr 29. No abstract available.
PMID: 20428204
[PubMed - indexed for MEDLINE]
Related citations
8.
Study of the effects of proteasome inhibitors on ribosomal protein S19 (RPS19) mutants, identified in patients with Diamond-Blackfan anemia.
Crétien A, Hurtaud C, Moniz H, Proust A, Marie I, Wagner-Ballon O, Choesmel V, Gleizes PE, Leblanc T, Delaunay J, Tchernia G, Mohandas N, Da Costa L.
Haematologica. 2008 Nov;93(11):1627-34. Epub 2008 Sep 2.
PMID:
18768533
[PubMed - indexed for MEDLINE]
Free Article
Related citations
9.
Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice.
Wagner-Ballon O, Pisani DF, Gastinne T, Tulliez M, Chaligné R, Lacout C, Auradé F, Villeval JL, Gonin P, Vainchenker W, Giraudier S.
Blood
. 2007 Jul 1;110(1):345-53. Epub 2007 Mar 20.
PMID: 17374740
[PubMed - indexed for MEDLINE]
Free Article
Related citations
10.
Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.
Raoul W, Wagner-Ballon O, Saber G, Hulin A, Marcos E, Giraudier S, Vainchenker W, Adnot S, Eddahibi S, Maitre B.
Respir Res
. 2007 Jan 30;8:8.
PMID: 17263874
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations
11.
Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development.
Gastinne T, Vigant F, Lavenu-Bombled C, Wagner-Ballon O, Tulliez M, Chagraoui H, Villeval JL, Lacout C, Perricaudet M, Vainchenker W, Benihoud K, Giraudier S.
Exp Hematol
. 2007 Jan;35(1):64-74.
PMID: 17198875
[PubMed - indexed for MEDLINE]
Related citations
12.
Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
Wagner-Ballon O, Chagraoui H, Prina E, Tulliez M, Milon G, Raslova H, Villeval JL, Vainchenker W, Giraudier S.
J Immunol
. 2006 Jun 1;176(11):6425-33.
PMID: 16709799
[PubMed - indexed for MEDLINE]
Free Article
Related citations
13.
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.
J Exp Med
. 2005 Oct 17;202(8):1075-85.
PMID: 16230475
[PubMed - indexed for MEDLINE]
Free PMC Article
Related citations

Vous êtes ici : Accueil En savoir plus... Publications scientifiques Dr Orianne WAGNER-BALLON